Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status

• Egile Nagusiak: Kunio Yui (Egilea), George Imataka (Egilea), Hitomi Sasaki (Egilea), Yohei Kawasaki (Egilea), Tohru Okanshi (Egilea), Ryoichi Shiroki (Egilea), Shigemi Yoshihara (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2019-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

We investigated the effect of the mammalian target of rapamycin (mTOR) inhibitor everolimus on tuberous sclerosis complex- (TSC-) associated autistic symptoms and focal seizures with impaired awareness in a female child with TSC. We further evaluated the relationship between improved autistic sympto...